rdf:type |
|
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0007634,
umls-concept:C0025202,
umls-concept:C0030705,
umls-concept:C0085358,
umls-concept:C0679058,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1519667,
umls-concept:C1547699,
umls-concept:C1706438,
umls-concept:C1880022,
umls-concept:C2239176,
umls-concept:C2348480,
umls-concept:C2698600,
umls-concept:C2700640
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-12-15
|
pubmed:abstractText |
Members of the melanoma antigen encoding gene family are expressed in tumors of different histological types but not in normal tissue. For this reason, they are attractive targets for cancer immunotherapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD8,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/MAGEA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MAGEA3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Melanoma-Specific Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0168-8278
|
pubmed:author |
pubmed-author:CavalloCristinaC,
pubmed-author:CrafaPellegrinoP,
pubmed-author:FerrariCarloC,
pubmed-author:MissaleGabrieleG,
pubmed-author:OrlandiniAlessandraA,
pubmed-author:PelosiGuidoG,
pubmed-author:PilliMassimoM,
pubmed-author:ScandroglioRenatoR,
pubmed-author:SolianiPaoloP,
pubmed-author:SpagnoliGiulio CGC,
pubmed-author:UggeriJacopoJ,
pubmed-author:ZerbiniAlessandroA,
pubmed-author:ZieglerStefanieS
|
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
102-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14672620-Aged,
pubmed-meshheading:14672620-Aged, 80 and over,
pubmed-meshheading:14672620-Antigens, CD8,
pubmed-meshheading:14672620-Antigens, Neoplasm,
pubmed-meshheading:14672620-CD8-Positive T-Lymphocytes,
pubmed-meshheading:14672620-Carcinoma, Hepatocellular,
pubmed-meshheading:14672620-Female,
pubmed-meshheading:14672620-Gene Expression,
pubmed-meshheading:14672620-Humans,
pubmed-meshheading:14672620-Immunohistochemistry,
pubmed-meshheading:14672620-Liver Neoplasms,
pubmed-meshheading:14672620-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:14672620-Male,
pubmed-meshheading:14672620-Melanoma-Specific Antigens,
pubmed-meshheading:14672620-Middle Aged,
pubmed-meshheading:14672620-Neoplasm Proteins,
pubmed-meshheading:14672620-Phenotype,
pubmed-meshheading:14672620-RNA, Messenger,
pubmed-meshheading:14672620-Staining and Labeling
|
pubmed:year |
2004
|
pubmed:articleTitle |
Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma.
|
pubmed:affiliation |
Divisione Malattie Infettive ed Epatologia, Azienda Ospedaliera Universitaria di Parma, Via Gramsci 14, 43100 Parma, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|